Etretinate approved.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000818:Animals; D005050:Etretinate / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy*
D005050:Etretinate